CurifyLabs
Develops 3D printing-based technology for medicine compounding, enabling more flexible preparation of customized pharmaceuticals.
Overview
CurifyLabs builds technology for 3D printing-based medicine compounding, applying additive manufacturing methods to the preparation of pharmaceuticals. Its offering is aimed at organizations involved in compounding medicines and personalized drug preparation. The company’s key differentiator is its use of 3D printing as the basis for compounding workflows, positioning it within advanced pharmaceutical manufacturing rather than core AI. CurifyLabs raised a $12 million Series A in July 2026 to expand its medicine compounding platform.
Funding History
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding
Frequently Asked Questions
- How much has CurifyLabs raised in total?
- CurifyLabs has raised a total of $12M across 1 funding round.
- Who are CurifyLabs's investors?
- CurifyLabs's investors include Sandwater, HealthCap.
- What does CurifyLabs do?
- CurifyLabs builds technology for 3D printing-based medicine compounding, applying additive manufacturing methods to the preparation of pharmaceuticals. Its offering is aimed at organizations involved in compounding medicines and personalized drug preparation. The company’s key differentiator is its use of 3D printing as the basis for compounding workflows, positioning it within advanced pharmaceutical manufacturing rather than core AI. CurifyLabs raised a $12 million Series A in July 2026 to expand its medicine compounding platform.
- Where is CurifyLabs headquartered?
- CurifyLabs is headquartered in Helsinki, Finland.
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.